These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 33938078)

  • 1. Caged-in: Successful percutaneous closure of left atrial appendage with Watchman-FLX in the presence of proximal thrombus.
    Briosa E Gala A; Pope MTB; Newton JD; Dawkins S; Betts TR
    J Cardiovasc Electrophysiol; 2021 Jun; 32(6):1655-1657. PubMed ID: 33938078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcatheter cerebral embolic protection during WATCHMAN procedure in two patients with persistent left atrial appendage thrombus: Case report with review of the literature.
    Tan BE; Depta JP
    Catheter Cardiovasc Interv; 2021 Feb; 97(2):365-368. PubMed ID: 32538522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extending percutaneous left atrial appendage closure indications using the AMPLATZER™ Cardiac Plug device in patients with persistent left atrial appendage thrombus: The thrombus trapping technique.
    Jalal Z; Iriart X; Dinet ML; Selly JB; Tafer N; Renou P; Sibon I; Thambo JB
    Arch Cardiovasc Dis; 2016 Dec; 109(12):659-666. PubMed ID: 27402154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First experience with the Watchman FLX occluder for percutaneous left atrial appendage closure.
    Seeger J; Birkemeyer R; Rottbauer W; Wöhrle J
    Cardiovasc Revasc Med; 2017; 18(7):512-516. PubMed ID: 28495117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Device-Related Thrombosis After Percutaneous Left Atrial Appendage Occlusion for Atrial Fibrillation.
    Fauchier L; Cinaud A; Brigadeau F; Lepillier A; Pierre B; Abbey S; Fatemi M; Franceschi F; Guedeney P; Jacon P; Paziaud O; Venier S; Deharo JC; Gras D; Klug D; Mansourati J; Montalescot G; Piot O; Defaye P
    J Am Coll Cardiol; 2018 Apr; 71(14):1528-1536. PubMed ID: 29622159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left Atrial Appendage Occlusion in Patients With Thrombus in Left Atrial Appendage.
    Sahiner L; Coteli C; Kaya EB; Ates A; Kilic GS; Yorgun H; Aytemir K
    J Invasive Cardiol; 2020 Jun; 32(6):222-227. PubMed ID: 32330118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left atrial appendage closure in patients with prohibitive anatomy: Insights from PINNACLE FLX.
    Ellis CR; Jackson GG; Kanagasundram AN; Mansour M; Sutton B; Houle VM; Kar S; Doshi S; Osorio J
    Heart Rhythm; 2021 Jul; 18(7):1153-1161. PubMed ID: 33957090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct current cardioversion practices following percutaneous left atrial appendage closure.
    Bhuta S; Shaaban A; Binda NC; Antaki J; Augostini RS; Kalbfleisch SJ; Savona SJ; Okabe T; Houmsse M; Afzal MR; Daoud EG; Hummel JD
    J Cardiovasc Electrophysiol; 2023 Aug; 34(8):1698-1705. PubMed ID: 37493499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Feasibility of Left Atrial Appendage Occlusion for Left Atrial Appendage Thrombus in Patients With Persistent Atrial Fibrillation.
    Lee OH; Kim JS; Pak HN; Hong GR; Shim CY; Uhm JS; Cho IJ; Joung B; Yu CW; Lee HJ; Kang WC; Shin ES; Choi RK; Lim DS; Jang Y
    Am J Cardiol; 2018 Jun; 121(12):1534-1539. PubMed ID: 29631803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical impact of incomplete left atrial appendage closure with the Watchman Device in patients with atrial fibrillation: a PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) substudy.
    Viles-Gonzalez JF; Kar S; Douglas P; Dukkipati S; Feldman T; Horton R; Holmes D; Reddy VY
    J Am Coll Cardiol; 2012 Mar; 59(10):923-9. PubMed ID: 22381428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Watchman FLX Implantation for Challenging Left Atrial Appendage Anatomy: Case-Based Discussion.
    Joury A; Englert JAR; Bernard M; Jenkins JS; Dinshaw H; Gilliland Y; Qamruddin S
    Curr Probl Cardiol; 2022 Sep; 47(9):101266. PubMed ID: 35644503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Percutaneous closure of left atrial appendage in non-valvular atrial fibrillation--international and Hungarian experiences].
    Fontos G; Andréka P; Temesvári A; Wéber D; Szatmári A
    Orv Hetil; 2010 May; 151(18):725-34. PubMed ID: 20409999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amulet or Watchman Device for Percutaneous Left Atrial Appendage Closure: Primary Results of the SWISS-APERO Randomized Clinical Trial.
    Galea R; De Marco F; Meneveau N; Aminian A; Anselme F; Gräni C; Huber AT; Teiger E; Iriart X; Babongo Bosombo F; Heg D; Franzone A; Vranckx P; Fischer U; Pedrazzini G; Bedogni F; Räber L; Valgimigli M
    Circulation; 2022 Mar; 145(10):724-738. PubMed ID: 34747186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Watchman FLX vs. Watchman 2.5 in a Dual-Center Left Atrial Appendage Closure Cohort: the WATCH-DUAL study.
    Galea R; Mahmoudi K; Gräni C; Elhadad S; Huber AT; Heg D; Siontis GCM; Brugger N; Sebag F; Windecker S; Valgimigli M; Landolff Q; Roten L; Amabile N; Räber L
    Europace; 2022 Oct; 24(9):1441-1450. PubMed ID: 35253840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Device-Related Thrombus After Left Atrial Appendage Closure: Incidence, Predictors, and Outcomes.
    Dukkipati SR; Kar S; Holmes DR; Doshi SK; Swarup V; Gibson DN; Maini B; Gordon NT; Main ML; Reddy VY
    Circulation; 2018 Aug; 138(9):874-885. PubMed ID: 29752398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility of left atrial appendage device closure following chronically failed surgical ligation.
    Ellis CR; Metawee M; Piana RN; Bennett JM; Pretorius M; Deegan RJ
    Heart Rhythm; 2019 Jan; 16(1):12-17. PubMed ID: 30012348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN.
    Søndergaard L; Wong YH; Reddy VY; Boersma LVA; Bergmann MW; Doshi S; Kar S; Sievert H; Wehrenberg S; Stein K; Holmes DR
    JACC Cardiovasc Interv; 2019 Jun; 12(11):1055-1063. PubMed ID: 31171282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence, predictors and outcomes of device-related thrombus after left atrial appendage closure with the WATCHMAN device-Insights from the EWOLUTION real world registry.
    Sedaghat A; Nickenig G; Schrickel JW; Ince H; Schmidt B; Protopopov AV; Betts TR; Gori T; Sievert H; Mazzone P; Grygier M; Wald C; Vireca E; Allocco D; Boersma LVA;
    Catheter Cardiovasc Interv; 2021 Jun; 97(7):E1019-E1024. PubMed ID: 33417282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous Left Atrial Appendage Closure with the LAmbre Device Protected by a Cerebral Protection System in a 76-Year-Old Man with Persistent Left Atrial Appendage Thrombus.
    Popescu SȘ; Heeger CH; Keelani A; Tilz RR
    Am J Case Rep; 2022 Sep; 23():e937063. PubMed ID: 36101478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Closure of the left atrial appendage using percutaneous transcatheter occlusion devices.
    Gianni C; Anannab A; Sahore Salwan A; Della Rocca DG; Natale A; Horton RP
    J Cardiovasc Electrophysiol; 2020 Aug; 31(8):2179-2186. PubMed ID: 32249473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.